The White House on Tuesday held a summit with vaccine makers and scientists as it pushed for "next generation" COVID-19 vaccines that offer broader and more durable protection against the virus.
Jul 26, 2022
0
94
Even though most viruses cause infection directly through mucosal cells, the vast majority of vaccines are administered intramuscularly in a cellular mismatch that doesn't always produce optimum immunity.
Adults (aged 18 or older) hospitalized with COVID-19 are at higher risk of complications and death than those with influenza, despite being younger and having fewer chronic illnesses, according to a retrospective cohort study ...
Apr 22, 2022
0
140
Researchers from the Medway School of Pharmacy (a partnership between the universities of Kent and Greenwich) have helped isolate the Lloviu virus (LLOV)—a close relative of Ebola virus—for the first time, highlighting ...
May 6, 2022
0
211
Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective treatment for first recurrent ...
Jun 2, 2022
0
3
Doctors in France are treating a critically ill patient infected with the South African coronavirus variant, four months after he recovered from COVID-19, in what study authors said was the first case of its kind.
Feb 12, 2021
0
383
For 60 years, doctors and scientists searched for a vaccine against a common virus that, while sometimes deadly, is little known to the public. The hunt is over.
May 6, 2023
0
26
People with the "hybrid immunity" of having been both fully vaccinated and previously infected with COVID-19 have the strongest protection against the virus, two new studies said on Friday.
Apr 1, 2022
0
207
Infectious diseases expert George Thompson has been studying and treating fungal diseases for over two decades. He monitors their spread, symptoms and relative risks. Lately, he has been more concerned about a rising threat: ...
Nov 21, 2022
0
237
A new study presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, shows that the antibody—but not the T-cell—response to the first ...
Jul 9, 2021
0
2
